000 | 01124 a2200301 4500 | ||
---|---|---|---|
005 | 20250515044607.0 | ||
264 | 0 | _c20070103 | |
008 | 200701s 0 0 eng d | ||
022 | _a1873-5592 | ||
024 | 7 |
_a10.2174/138945006778559184 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWinkler, Dirk | |
245 | 0 | 0 |
_aGenetics, gene expression, and targeted therapies in chronic lymphocytic leukemia. _h[electronic resource] |
260 |
_bCurrent drug targets _cOct 2006 |
||
300 |
_a1313-27 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xgenetics |
650 | 0 | 4 |
_aGene Targeting _xmethods |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLeukemia, Lymphocytic, Chronic, B-Cell _xgenetics |
700 | 1 | _aDöhner, Hartmut | |
700 | 1 | _aStilgenbauer, Stephan | |
773 | 0 |
_tCurrent drug targets _gvol. 7 _gno. 10 _gp. 1313-27 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2174/138945006778559184 _zAvailable from publisher's website |
999 |
_c16647873 _d16647873 |